- Higher ω6-PUFA/ω3-PUFA ratio predicts Alzheimer's-type dementia and cognitive decline more strongly than individual ω3-PUFA levels.
- A high baseline ω6/ω3 ratio associates with faster cognitive decline, while longitudinal improvements in the ratio slow decline.
- Mendelian randomisation indicates a non-causal genetic link; higher ω3 levels correlate with lower ω6 species, supporting dietary modulation for prevention.
Alzheimers Dement. 2026 Jun;22(6):e71590. doi: 10.1002/alz.71590.
ABSTRACT
INTRODUCTION: The polyunsaturated fatty acids (PUFAs) omega-6 (ω6) and omega-3 (ω3) are linked to cognitive performance and Alzheimer’s-type dementia (DAT), but ω3-PUFA supplementation offers limited benefits. We propose that the ω6-PUFA/ω3-PUFA ratio better explains cognitive decline and DAT risk.
METHODS: PUFA profiles were examined in the AgeCoDe cohort (n = 3327) and MAPT trial (n = 1679). Cox and linear mixed models evaluated associations of individual PUFAs and the ω6-PUFA/ω3-PUFA ratio with DAT progression and cognitive decline. Mendelian randomization (MR) assessed genetic causal effects. The effect of ω3-PUFA on ω6-PUFA levels was analyzed.
RESULTS: Higher ω6-PUFA/ω3-PUFA ratio increased DAT risk beyond ω3-PUFA levels alone. A baseline high (detrimental) ratio predicted faster cognitive decline, whereas longitudinal improvements slowed decline. MR supported a genetic non-causal link. Higher ω3-PUFA levels correlated with lower ω6-PUFA species.
DISCUSSION: The ω6-PUFA/ω3-PUFA ratio better predicts cognitive decline and DAT progression than individual PUFAs, suggesting that dietary adjustments may help prevent dementia.
PMID:42271192 | DOI:10.1002/alz.71590
Share Evidence Blueprint
Save to Google Notes
Search Google Scholar
Save as PDF
⭐ My Revision List
